MicroRNA (miRNA) Market to Reach New Heights with 13% CAGR by 2031 | The Insight Partners

United States of America – September 22, 2025 â€“ The Insight Partners is pleased to announce the release of its latest report, â€œMicroRNA (miRNA) Market: An In-depth Analysis of Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025–2031.” The report delivers a comprehensive view of the MicroRNA (miRNA) Market and projects a strong growth trajectory with a CAGR of 13% from 2025 to 2031.

Overview of MicroRNA (miRNA) Market

The MicroRNA (miRNA) Market is gaining momentum as miRNAs are increasingly recognized as biomarkers for diagnostics and therapeutic targets in precision medicine. Their role in regulating gene expression has fueled extensive applications in oncology, cardiovascular diseases, neurology, and infectious disease research. With rising investments in molecular diagnostics and next-generation sequencing technologies, the market is poised for rapid expansion.

Download Sample PDF Copy https://www.theinsightpartners.com/sample/TIPRE00006698/

Key Findings and Insights

Market Size and Growth

• Market Growth Rate: Projected to grow at a CAGR of 13% during 2025–2031.
• Growth Drivers: Growing use of miRNA in disease diagnostics, rising prevalence of chronic diseases, rapid advances in sequencing and profiling technologies, and increasing R&D collaborations between biotech firms and academic institutes.

MicroRNA (miRNA) Market Segmentation

• By Product:
• Instruments
• Consumables
• Services
• By Sample Collection:
• miRNA cDNA Synthesis
• miRNA Profiling and Purification
• Next Generation Sequencing
• Microarray
• Real Time PCR
• By Application:
• Cardiovascular Diseases
• Cancer
• Neurological Diseases
• Immunological Disorders
• Infectious Diseases
• By End User:
• Biotechnology and Pharmaceutical Companies
• Academic and Government Research Institutes

Spotting Emerging Trends

• Technological Advancements: Integration of AI-driven data analysis in miRNA profiling, expansion of next-generation sequencing capabilities, and development of cost-effective PCR assays.
• Changing Research Focus: Growing emphasis on personalized medicine and non-invasive liquid biopsy testing.
• Regulatory Landscape: Rising focus on clinical validation and FDA/EMA approvals for miRNA-based diagnostic kits.

Growth Opportunities

• Expansion of cancer diagnostics and therapeutics using miRNA biomarkers.
• Increasing adoption of non-invasive diagnostic tools in infectious and neurological diseases.
• Strategic collaborations between biotech companies and academic institutes to accelerate clinical research.
• Strong potential for growth in emerging economies with rising healthcare investments and demand for advanced diagnostics.

Market Leaders and Key Company Profiles

• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Horizon Discovery Ltd.
• Synlogic
• QIAGEN
• GeneCopoeia, Inc.
• New England Biolabs
• Quantabio
• NanoString

Conclusion

The MicroRNA (miRNA) Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025–2031 report provides essential insights for stakeholders seeking to capitalize on the growing potential of miRNA technologies. With in-depth analysis of competitive landscapes, market dynamics, and regulatory environments, this report supports informed decision-making to drive business growth in a high-potential sector.

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:

Contact Person: Ankit Mathur

E-mail: ankit.mathur@theinsightpartners.com

Phone: +1-646-491-9876

Also Available in: 日本 | 한국어 | Français | لعربية | 中文 | Italiano | Español | Deutsch